Carlos Luri-Rey

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Immune Response

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer discovery

Science advances

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Alvaro Teijeira, Saray Garasa, María Carmen Ochoa, Sandra Sanchez-Gregorio, Gabriel Gomis, Carlos Luri-Rey, Rafael Martinez-Monge, Beatrice Pinci, Karmele Valencia, Belen Palencia, Benigno Barbes, Elixabet Bolaños, Arantza Azpilikueta, Marina Garcia-Cardosa, Javier Burguete, Iñaki Eguren, Eneko Garate-Soraluze, Pedro Berraondo, Jose-Luis Perez-Gracia, Carlos E De Andrea, Maria E Rodríguez-Ruiz, Ignacio Melero Bermejo
Low-dose ionizing γ-radiation elicits the extrusion of neutrophil extracellular traps. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Javier Glez-Vaz, Arantza Azpilikueta, María Carmen Ochoa, Irene Olivera, Gabriel Gomis, Assunta Cirella, Carlos Luri-Rey, Maite Alvarez, Jose-Luis Perez-Gracia, Sergio Ciordia, Iñaki Eguren, Raluca Alexandru, Pedro Berraondo, Carlos E De Andrea, Alvaro Teijeira, Fernando Corrales, Juan M Zapata, Ignacio Melero Bermejo
CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects. Science advances 9 (33) (2023)
Irene Olivera, Carlos Luri-Rey, Alvaro Teijeira, Iñaki Eguren, Gabriel Gomis, Belen Palencia, Pedro Berraondo, Ignacio Melero Bermejo
Facts and hopes on neutralization of protumor inflammatory mediators in cancer immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Carlos Luri-Rey, Iñaki Eguren, Ignacio Matos, Pedro Berraondo, Ignacio Melero Bermejo
Druggable targets in cytokine release syndromes. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Ignacio Melero Bermejo, Miguel F Sanmamed, Javier Glez-Vaz, Carlos Luri-Rey, Jun Wang, Lieping Chen
CD137 (4-1BB)-Based Cancer Immunotherapy on Its 25th Anniversary. Cancer discovery 13 (3) (2023)
Ignacio Melero Bermejo, Maria C Ochoa, Carmen Molina, Sandra Sanchez-Gregorio, Saray Garasa, Carlos Luri-Rey, Sandra Hervas-Stubbs, Noelia Casares, Edurne Elizalde, Gabriel Gomis, Assunta Cirella, Pedro Berraondo, Alvaro Teijeira, Maite Alvarez
Intratumoral co-injection of NK cells and NKG2A-neutralizing monoclonal antibodies. EMBO molecular medicine (2023)
Ignacio Melero Bermejo, Miguel F Sanmamed, Javier Glez-Vaz, Carlos Luri-Rey, Jun Wang, Lieping Chen
CD137 (4-1BB)-Based Cancer Immunotherapy on Its 25th Anniversary. Cancer discovery (2022)
Alvaro Teijeira, Saray Garasa, Carlos Luri-Rey, Carlos E De Andrea, Maria Gato-Cañas, Carmen Molina, Tsuneyasu Kaisho, Assunta Cirella, Arantza Azpilikueta, Steffanie K Wculek, Josune Egea, Irene Olivera, Inmaculada Rodriguez, Ana Rouzaut, Vladislav V Verkhusha, Karmele Valencia, David Sancho, Pedro Berraondo, Ignacio Melero Bermejo
Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy. Cancer research 82 (23) (2022)
Assunta Cirella, Elixabet Bolaños, Claudia Augusta Di Trani, Carlos E De Andrea, Sandra Sanchez-Gregorio, Iñaki Etxeberría, Jose Gonzalez-Gomariz, Irene Olivera, Davide Brocco, Javier Glez-Vaz, Carlos Luri-Rey, Arantza Azpilikueta, Inmaculada Rodriguez, Myriam Fernandez-Sendin, Josune Egea, Iñaki Eguren, Miguel F Sanmamed, Belen Palencia, Alvaro Teijeira, Pedro Berraondo, Ignacio Melero Bermejo
Intratumoral gene transfer of mRNAs encoding interleukin-12 in combination with decoy-resistant interleukin-18 improves local and systemic antitumor immunity. Cancer immunology research (2022)